Amy Kamin - Endymed Ltd CEO of EndyMed USA

Ms. Amy Kamin will no longer serve as Senior Vice PresidentBusiness DevelopmentNorth America at Endymed Medical Ltd, a Subsidiary of Endymed Ltd, effective June 20, 2018. She held this role from June 2010. Additionally, she will no longer serve as Chief Executive Officer at Endymed Medical Inc, a subsubsidiary of Endymed Ltd, effective June 20, 2018. She held this role since July 2013. She holds a Bachelors degree in Communications and Business from Chatham University, Pittsburgh, Pennsylvania.
Age: 56        

Management Efficiency

The company has return on total asset (ROA) of 13.08 % which means that it generated profit of $13.08 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 52.69 % meaning that it generated $52.69 on every $100 dollars invested by stockholders.
The company has accumulated 1K in total debt. Endymed Ltd has Current Ratio of 2.56 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

EndyMed Medical Ltd., a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. EndyMed Medical Ltd. was founded in 2007 and is based in New York, New York. Endymed Ltd operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.Endymed Ltd (ENDY) is traded on Tel Aviv Stock Exchange in Israel and employs 10 people.

Endymed Ltd Leadership Team

Amir Schori, Vice President - Business Development
Lee Gabay, Controller
Ben Feldman, CFO
Rami Aviram, Vice President - Finance
Yoram Hert, CEO, Endymed Medical Ltd.
Amiram Goldman, External Director
Eran Naor, External Director, Independent Director
Ronen Zadok, External Director
Amy Kamin, CEO of EndyMed USA
Elad Magal, CEO
Yoram Harth, Founder, Director & Chief Medical Officer
Yuan Yibing, Director
Batsheva Elran, Director
Sima Witman, Vice President - Research & Development
Oren Maymon, Vice President - Operations
Lior Cohen, Vice President of Sales
Yosef BarOn, CEO
Atzmon Shlush, Vice President - Operations
Eran Ishay, Vice President - Research & Development
Jan Jingran, Director
Sharon Dovev, Director of Marketing
Lior Vider, External Director
Daniel Lishinsky, Vice President - Research & Development
Idan Alfa, Finance Director
Yocheved Dvir, Director
Annie Jin, Director
Lee Roth, Finance Director
Zvika Lifschitz, Vice President - Finance
Ofer Zvi, Director
Daniel Lischinsky, Founder and VP of RandD
Moshe Cohen, Internal Auditor
Frank Iannelli, Corporate Executive

Stock Performance Indicators

Current Sentiment - ENDY

Endymed Ltd Investor Sentiment

Macroaxis portfolio users are insensible in their opinion about investing in Endymed Ltd. What is your opinion about investing in Endymed Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish

Endymed Ltd Pair Correlation

Equities Pair Trading Analysis

Additionally see Investing Opportunities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.